001026969 001__ 1026969
001026969 005__ 20250204113859.0
001026969 0247_ $$2doi$$a10.1016/j.bpsc.2024.04.010
001026969 0247_ $$2ISSN$$a2451-9022
001026969 0247_ $$2ISSN$$a2451-9030
001026969 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-03548
001026969 0247_ $$2pmid$$a38679325
001026969 0247_ $$2WOS$$aWOS:001333890900001
001026969 037__ $$aFZJ-2024-03548
001026969 082__ $$a610
001026969 1001_ $$0P:(DE-Juel1)184653$$aKasper, Jan$$b0
001026969 245__ $$aResting state changes in aging and Parkinson’s disease are shaped by underlying neurotransmission – a normative modeling study
001026969 260__ $$aAmsterdam [u.a.]$$bElsevier Inc.$$c2024
001026969 3367_ $$2DRIVER$$aarticle
001026969 3367_ $$2DataCite$$aOutput Types/Journal article
001026969 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1729491056_22763
001026969 3367_ $$2BibTeX$$aARTICLE
001026969 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001026969 3367_ $$00$$2EndNote$$aJournal Article
001026969 500__ $$aThis work was supported by the European Union’s Horizon 2020 research and innovation program (Grant No. 826421 [to JD]); TheVirtualBrain-Cloud; the European Union’s Horizon 2020 research and innovation program (Grant No. 945539 [to SC and SBE]) (Human Brain Project SGA3); and the Federal Ministry of Education and Research and the Max Planck Society, Germany (to LDL).
001026969 520__ $$aBackgroundHuman healthy and pathological aging is linked to a steady decline in brain resting-state activity and connectivity measures. The neurophysiological mechanisms that underlie these changes remain poorly understood.MethodsMaking use of recent developments in normative modeling and availability of in vivo maps for various neurochemical systems, we tested in the UK Biobank cohort (n = 25,917) whether and how age- and Parkinson’s disease–related resting-state changes in commonly applied local and global activity and connectivity measures colocalize with underlying neurotransmitter systems.ResultsWe found that the distributions of several major neurotransmitter systems including serotonergic, dopaminergic, noradrenergic, and glutamatergic neurotransmission correlated with age-related changes across functional activity and connectivity measures. Colocalization patterns in Parkinson’s disease deviated from normative aging trajectories for these, as well as for cholinergic and GABAergic (gamma-aminobutyric acidergic) neurotransmission. The deviation from normal colocalization of brain function and GABAA correlated with disease duration.ConclusionsThese findings provide new insights into molecular mechanisms underlying age- and Parkinson’s-related brain functional changes by extending the existing evidence elucidating the vulnerability of specific neurochemical attributes to normal aging and Parkinson’s disease. The results particularly indicate that alongside dopamine and serotonin, increased vulnerability of glutamatergic, cholinergic, and GABAergic systems may also contribute to Parkinson’s disease–related functional alterations. Combining normative modeling and neurotransmitter mapping may aid future research and drug development through deeper understanding of neurophysiological mechanisms that underlie specific clinical conditions.
001026969 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001026969 536__ $$0G:(EU-Grant)945539$$aHBP SGA3 - Human Brain Project Specific Grant Agreement 3 (945539)$$c945539$$fH2020-SGA-FETFLAG-HBP-2019$$x1
001026969 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001026969 7001_ $$0P:(DE-Juel1)131675$$aCaspers, Svenja$$b1
001026969 7001_ $$0P:(DE-Juel1)192260$$aLotter, Leon D.$$b2
001026969 7001_ $$0P:(DE-Juel1)131684$$aHoffstaedter, Felix$$b3
001026969 7001_ $$0P:(DE-Juel1)131678$$aEickhoff, Simon B.$$b4
001026969 7001_ $$0P:(DE-Juel1)177727$$aDukart, Juergen$$b5$$eCorresponding author
001026969 773__ $$0PERI:(DE-600)2879089-3$$a10.1016/j.bpsc.2024.04.010$$gp. S2451902224001125$$n10$$p986-997$$tBiological psychiatry / Cognitive neuroscience and neuroimaging$$v9$$x2451-9022$$y2024
001026969 8564_ $$uhttps://juser.fz-juelich.de/record/1026969/files/1-s2.0-S2451902224001125-main.pdf$$yOpenAccess
001026969 8564_ $$uhttps://juser.fz-juelich.de/record/1026969/files/1-s2.0-S2451902224001125-main.gif?subformat=icon$$xicon$$yOpenAccess
001026969 8564_ $$uhttps://juser.fz-juelich.de/record/1026969/files/1-s2.0-S2451902224001125-main.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001026969 8564_ $$uhttps://juser.fz-juelich.de/record/1026969/files/1-s2.0-S2451902224001125-main.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001026969 8564_ $$uhttps://juser.fz-juelich.de/record/1026969/files/1-s2.0-S2451902224001125-main.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001026969 8767_ $$d2024-07-30$$eHybrid-OA$$jDEAL
001026969 909CO $$ooai:juser.fz-juelich.de:1026969$$pdnbdelivery$$popenCost$$pec_fundedresources$$pVDB$$pdriver$$pOpenAPC_DEAL$$popen_access$$popenaire
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)184653$$aForschungszentrum Jülich$$b0$$kFZJ
001026969 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)184653$$a HHU Düsseldorf$$b0
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131675$$aForschungszentrum Jülich$$b1$$kFZJ
001026969 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)131675$$a HHU Düsseldorf$$b1
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)192260$$aForschungszentrum Jülich$$b2$$kFZJ
001026969 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)192260$$a Max Planck School of Cognition, Leipzig$$b2
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131684$$aForschungszentrum Jülich$$b3$$kFZJ
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131678$$aForschungszentrum Jülich$$b4$$kFZJ
001026969 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)131678$$a HHU Düsseldorf$$b4
001026969 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177727$$aForschungszentrum Jülich$$b5$$kFZJ
001026969 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001026969 9141_ $$y2024
001026969 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
001026969 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
001026969 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
001026969 915pc $$0PC:(DE-HGF)0125$$2APC$$aDEAL: Elsevier 09/01/2023
001026969 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001026969 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-24
001026969 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001026969 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-24
001026969 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBIOL PSYCHIAT-COGN N : 2022$$d2024-12-06
001026969 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bBIOL PSYCHIAT-COGN N : 2022$$d2024-12-06
001026969 9201_ $$0I:(DE-Juel1)INM-1-20090406$$kINM-1$$lStrukturelle und funktionelle Organisation des Gehirns$$x0
001026969 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x1
001026969 980__ $$ajournal
001026969 980__ $$aVDB
001026969 980__ $$aUNRESTRICTED
001026969 980__ $$aI:(DE-Juel1)INM-1-20090406
001026969 980__ $$aI:(DE-Juel1)INM-7-20090406
001026969 980__ $$aAPC
001026969 9801_ $$aAPC
001026969 9801_ $$aFullTexts